The third Health Care and Pharmaceuticals Market of the Americas, with articulated public and private Health Care Systems, service needs of a continental scale and a huge drug market.
The Brazilian pharmaceutical market as a whole exceeds USD 15 bln, with a strong national industry size, an articulate and dynamic supply chain and exports in the order of a billion dollars.

The key global Industry player are all present in Brazil, with direct subsidiaries and an aggressive local activity of Joint Ventures and Acquisitions.

The regulatory and juridical aspects of the market are key elements for a successful presence: rules are evolving and increasingly demanding and involve the total supply chain of market participants.
In view of these developments, ever more frequently the winning approach ends up being a combination of Acquisitions and Industrial – Technological agreements.